Nektar TherapeuticsNKTRNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank0
3Y CAGR-26.7%
5Y CAGR-28.9%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
-26.7%/yr
vs -24.2%/yr prior
5Y CAGR
-28.9%/yr
Consistent
Acceleration
-2.5pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.2x
Contraction
Streak
7 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$280.41M-7.7%
2024$303.85M-23.7%
2023$398.03M-44.0%
2022$710.60M-36.4%
2021$1.12B-27.4%
2020$1.54B-22.2%
2019$1.98B-8.0%
2018$2.15B+322.5%
2017$508.87M-10.5%
2016$568.87M-